Navigation Links
Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Date:3/3/2008

context of the agreement

signed with Merck in March 2006

-- Euro 1.0 million received from Pfizer in April 2007, following the

review of an Investigational New Drug (IND) submission by the U.S. FDA

for a new experimental medicine for the treatment of glaucoma,

developed under the collaboration agreement signed between Pfizer and

NicOx in August 2004

-- Euro 5.0 million received from Merck in July 2007, following the

initiation of the first in a series of planned clinical studies for the

first selected drug candidate, in accordance with the companies' major

collaborative agreement to develop new nitric oxide-donating

antihypertensive agents using NicOx' proprietary technology

These amounts, received by the Company, result from a firm commitment by the other contracting party and have been immediately recognized in revenues because NicOx will not have continuing involvement in the future development of the compounds that are the subject of the collaboration agreements mentioned above.

During the financial year 2007, NicOx also recognized the following sums, initially recorded as prepaid income, in revenues:

-- Euro 2.5 million corresponding to the initial payment of euro 5.0

million from Pfizer as a technology exclusivity fee, following the

March 2006 agreement that granted Pfizer rights to an exclusive

worldwide license to develop and commercialize new drug candidates

using NicOx' proprietary technology in the field of ophthalmology

-- Euro 3.0 million corresponding to the funding of the research

collaboration, pursuant to the above referenced agreement signed with

Pfizer in March 2006.

-- Euro 3.8 million corresponding to the initial payment of euro 9.2

million received from Merck following the signature in March 2006 of a

collaboration agreement for new antih
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... CHAPEL HILL, N.C. , Aug. 29, 2014 /PRNewswire/ ... Opinion Leaders (KOLs) can be the difference between a ... struggle to effectively map and stratify KOL targets – ... to build the type of strong relationships upon which ... recent research, savvy pharma companies have identified internal inconsistencies ...
(Date:8/29/2014)... Ore. , Aug. 29, 2014 /PRNewswire-iReach/ -- ... Accessory (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today ... voluntary recall to address a potential issue with ... used for the Axilla application of the SAM ...
(Date:8/29/2014)... MARLBOROUGH, Mass. , Aug. 29, 2014 /PRNewswire/ ... ) prospective, multinational study on stent removability and ... strictures has been published in the August issue ... The multinational study 1 is being conducted ... removal of fully covered self-expanding metal stents (FCSEMS) ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... COLUMBUS and ZANESVILLE, Ohio , May ... www.huntington.com ) has created a unique funding model to finance ... installation at one of the region,s largest health care providers, ... equipment finance deal will install a clinical information system ...
... YORK , May 12 Reportlinker.com announces that a new market research report is ... Ophthalmic Therapeutic Drugs: Technologies and Global Markets ... http://www.reportlinker.com/p0196569/Ophthalmic-Therapeutic-Drugs-Technologies-and-Global-Markets.html , , ... , , ...
Cached Medicine Technology:Huntington Financing Package Supports Major Regional Medical Center Electronic Medical Records Project 2Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 2Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 3Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 4Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 5Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 6Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 7Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 8Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 9Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 10Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 11Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 12Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 13Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 14Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 15Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 16Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 17Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 18Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 19Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 20Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 21Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 22Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 23Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 24Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 25
(Date:8/31/2014)... 31, 2014 MYMOBILEUNI (MMU) strategy ... social media marketing tools access to digital, resources, ... will utilize all tools to reach and collaborate ... our multiple learning channels. , MMU, today announced ... an authoring tool that applies social networking concepts ...
(Date:8/31/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... of bamboo veneers . Additionally, it has deiced offer ... high quality products. The promotion will last from today until ... its top quality veneers are hot in the global market. ... bamboo veneers. All these items are made according to our ...
(Date:8/31/2014)... LabDoor.com tests the purity and label accuracy ... their website, “We buy products in the same fashion ... online sites. No manufacturer-supplied samples are permitted at LabDoor.” ... LabDoor,” a recent study was performed on twenty of ... United States for Vitamin D3 content, heavy metal contamination, ...
(Date:8/31/2014)... 01, 2014 Top10BestSEOHosting.com, a reliable review ... and announces that FatCow, Arvixe and Hostgator are the ... plenty of ASP.NET hosting companies in the world, but ... complicated to run a reliable ASP.NET server than running ... skills. I firmly believe that FatCow, Arvixe and Hostgator ...
(Date:8/31/2014)... 01, 2014 UWDress.com, a renowned wedding ... a new range of elegant formal bridesmaid dresses ... promotion for its high quality special occasion outfits. All ... (up to 65% off). , Along with the ... free gifts. The company’s promotional formal bridesmaid outfits are ...
Breaking Medicine News(10 mins):Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 4Health News:Best ASP.NET Hosting Award for August 2014 Released By Top10BestSEOHosting.com 2Health News:Elegant Formal Bridesmaid Dresses Today Unveiled By UWDress.com 2
... University of Wisconsin-Madison Center of Excellence in Cancer Communications Research ... Breast cancer patients who pray in online support groups can ... many cancer patients pray in online support groups to help ... we are aware of that examines the psychological effects of ...
... to alleviate symptoms of early-stage Parkinson's disease, and may ... manage the brain disorder,// researchers said., ,A neupro ... used to study its effects on 277 people in ... patch is designed to convey a drug called ...
... a customised personal digital assistant (PDA) to dramatically ... said Thursday. ,Instead of fumbling with ... speech impairments express their needs in such everyday ... attention from an archive of commonly-used phrases and ...
... regarded as a psychological disorder. Dr Sabine Nissan from Karolinska ... Sweden. ,The researchers found out that a third ... suffer from other metabolic disorders. The study points of that ... imbalance. The patients may often be overeating due to hormonal ...
... suggests a link between a particular gene named ApoE-4 ... Neurobiology of Aging, published the results of the research. ... in causing Alzheimer’s disease. ,This research now is ... the possibility that occurrence of herpes infection earlier in ...
... may have a greater risk of getting prostate cancer, according ... families of men diagnosed with prostate cancer with other men ... cancer were related. ,The Journal of the National ... the factors responsible for prostate cancer and having more daughters ...
Cached Medicine News:Health News:Online Prayers Helps Cancer Patients 2Health News:Excessive Male Hormones can Cause Bulimia in Women 2Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 2Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 3Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 4Health News:Gender Of Children May Be Linked To Risk Of Prostate Cancer 2
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The link ribbed hip stem for cementless primary hip replacement surgery....
The cemented hip joint prosthesis system....
The Quatroloc primary hip system offers 35 primary stems to fit almost all femurs for primary hip arthroplasty....
Medicine Products: